Is the use of insulin analogues cost-effective?

被引：0
作者：
Steven Leichter
机构：
[1] Columbus Research Foundation,Center for Diabetes and Metabolism
来源：
Advances in Therapy | 2008年 / 25卷
关键词：
aspart; cost-effectiveness; detemir; glargine; insulin analogues; insulin pens; lispro; pharmacoeconomic models;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Many patients with diabetes fail to achieve their glycaemic targets despite clear evidence that glycaemic control can prevent or delay the development of costly complications in diabetes. This article describes how insulin analogues (insulins lispro, aspart, glulisine, glargine and detemir) may have a role to play in overcoming barriers to insulin acceptance and improving adherence with therapy, and examines their cost-effectiveness as determined in published studies.
引用
收藏
页码：285 / 299
页数：14
相关论文
共 177 条
[1]  
Stratton I.M.(2003)Economic costs of diabetes in the US in 2002 Diabetes Care 26 917-932
[2]  
Cull C.A.(2007)Standards of medical care in diabetes Diabetes Care 30 S1-S41
[3]  
Adler A.I.(2007)American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus Endocr Pract 13 1-66
[4]  
Matthews D.R.(2002)Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus JAMA 287 2563-2569
[5]  
Neil H.A.(2003)Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study JAMA 290 2159-2167
[6]  
Holman R.R.(1998)Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) Lancet 352 837-853
[7]  
Stratton I.M.(2006)Additive effects of glycaemia and blood pressure exposure on risk of complications in type 2 diabetes: a prospective observational study (UKPDS 75) Diabetologia 49 1761-1769
[8]  
Adler A.I.(2000)Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study BMJ 321 405-412
[9]  
Neil H.A.(2005)Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes N Engl J Med 353 2643-2653
[10]  
Klonoff D.C.(2000)An economic analysis of interventions for diabetes Diabetes Care 23 390-404
12345678910